DUSA Pharmaceuticals (DUSA) Reports In-Line Q2 EPS of 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Dusa Pharmaceuticals, Inc. (NYSE: DUSA) | Delayed: 56.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.65 | 52 Week High | $8.01 | |||
| Open | $56.65 | 52 Week Low | $4.10 | |||
| Day High | $56.65 | P/E | 472.08 | |||
| Day Low | $56.65 | EPS | $0.12 | |||
| Volume | 26 | |||||
